The relative risks of lymphatic metastasis and ANXA3 expression to DFS prognosis were 2.181 and 1.569, respectively, while those relative to OS prognosis were 2.052 and 1.698, respectively (Table 2). Here, ANXA3 is linked to Lymphatic Metastasis.